dephosphorylation

MT 63-78 is a specific and effective direct AMPK activator (EC50: 25 μM) that blocks prostate cancer growth by inhibiting the lipogenesis and mTORC1 pathways. It has antitumor effects and induces cell mitotic arrest and apoptosis.

EB-3D is a potent and selective choline kinase alpha 1 (ChoKα1) inhibitor (IC50: 1 μM) with anti-cancer activity.

NFAT Inhibitor (VIVIT peptide) is a cell-permeable compound that selectively inhibits the calcineurin-mediated dephosphorylation of NFAT.

DD1 (HUN85111) is a proteasome inhibitor that induces human myeloid tumor-selective apoptosis.

Cyt-PTPε Inhibitor-1 (A Inhibitor-1) is an inhibitor of cytosolic protein tyrosine phosphatase ε. Cyt-PTPε Inhibitor-1 blocks the dephosphorylation of c-Src and exhibits anti-osteoclastic activity.

Adenosine 5'-diphosphate (ADP) is a naturally occurring nucleotide derived from the dephosphorylation of ATP. Adenosine 5'-diphosphate is essential for cellular metabolism and induces platelet aggregation.

L-Ascorbic acid 2-phosphate trisodium (Sodium ascorbyl phosphate) is utilized in biocatalytic dephosphorylation for electric power generation and electrochemical detection assays.

Bacitracin Zinc is an antibiotic that interferes with the dephosphorylation of C55-isoprenyl pyrophosphate, interference for inhibition of cleavage of Tyr from Met-enkephalin(IC50=10 μM).

Cyclocreatine, a creatine analogue and substrate for creatine kinase, inhibits creatine metabolism and prostate cancer cell proliferation, improving cognitive, autistic and epileptic phenotypes in mouse models of creatine transporter deficiency (CTD).

Ceftaroline hydrochloride (T-91825 HCl, PPI-0903M HCl) is an N-phosphorylated cephalosporin antibiotic and the active form released upon dephosphorylation of the prodrug TAK-599 (ceftaroline fosamil) after it enters the body. Its mechanism of action involves high affinity for penicillin-binding protein 2a (PBP2a), which is associated with methicillin-resistant Staphylococcus aureus (MRSA) resistance (IC50 = 0.90 μg/mL). Ceftaroline hydrochloride kills various Gram-positive and Gram-negative bacteria by blocking bacterial cell wall synthesis, including resistant strains such as MRSA, methicillin-resistant Staphylococcus epidermidis (MRSE), and Streptococcus pneumoniae.

CGP74514A is a highly selective cyclin-dependent kinase 1 (CDK1) inhibitor with an IC50 of 25 nM. It effectively inhibits the activity of the CDK1/cyclin B complex, arrests the cell cycle at G2/M phase, and further induces apoptosis in tumor cells, showing promising application prospects in bladder cancer research.

CK37 is a specific inhibitor of hCKα (hChoKα, human choline kinase-α) which inhibits the enzymatic activity of hCKα by competitively binding to its choline-binding domain. CK37 impairs HCV RNA replication and viral protein expression, and disrupts the accumulation of PI4P in HCV-infected cells.

Lenaldekar (LDK) inhibits T-cell expansion and autoimmune encephalomyelitis. Lenaldekar causes dephosphorylation of members of the PI3 kinase/AKT/mTOR pathway and delays sensitive cells in late mitosis.

MLi-2 is a structurally novel, highly potent, and selective LRRK2 kinase inhibitor with central nervous system activity. MLi-2 exhibits exceptional potency in a purified LRRK2 kinase assay in vitro (IC50 = 0.76 nM), a cellular assay monitoring dephosphorylation of LRRK2 pSer935 LRRK2 (IC50 = 1.4 nM), and a radioligand competition binding assay (IC50 = 3.4 nM).

DDO-3733 is a conformational activator of Protein Phosphatase 5 (PP5) that functions independently of TRP, facilitating the dephosphorylation of downstream substrates.

Icerguastat (Sephin1) Carbonate, a Guanabenz derivative lacking α2-adrenergic activity, is a selective inhibitor of the phosphatase regulatory subunit PPP1R15A (R15A). It inhibits the dephosphorylation of eIF2α, thereby prolonging the protective response. Additionally, Icerguastat Carbonate exhibits antiprion activity.

RN341 is a LRRK2-specific type II kinase inhibitor (IC50 of 296 nM). It prevents the phosphorylation of LRRK2 by stabilizing an open conformation, thereby avoiding S935 dephosphorylation. Additionally, RN341 rescues LRRK2-mediated kinesin motility blockage by preventing microtubule binding. This compound effectively inhibits both wild-type and G2019S LRRK2 at the cellular level, offering a novel avenue for Parkinson's disease research.

CDK2-IN-47 is a potent CDK2 inhibitor with an IC50 of 0.21 μM. It demonstrates strong anticancer activity against MCF-7, HCT-116, and MGC-803 cell lines. CDK2-IN-47 effectively induces G1 cell cycle arrest, retinoblastoma protein (Rb) dephosphorylation, and significant apoptosis. It is applicable for research on breast, colorectal, and gastric cancers.

CDC25-IN-1 (Compound D11b) is an inhibitor of the cell division cycle 25 (CDC25) phosphatase. It effectively suppresses leukemia and colorectal cancer cells by blocking CDC25-mediated CDK1Tyr15 dephosphorylation, delaying the G2/M phase transition, and inducing caspase-dependent apoptosis and DNA damage. This compound is useful for researching leukemia and colorectal cancer.

AfaPhos1 is a novel Afatinib-based EGFRPhosTAC. It induces dephosphorylation of EGFR at the pY1068 and pY845 sites, leading to apoptosis (Apoptosis). AfaPhos1 exhibits anticancer activity against non-small cell lung cancer.

A-83586C is a depsipeptide antibiotic from Streptomyces karnatakensis with potent against Gram-positive activity in vitro. A-83586C acts as a highly potent inhibitor of beta-catenin/TCF4 signaling within cancer cells, while simultaneously downregulating o

MPT0B206 is a novel tubulin polymerization inhibitor. MPT0B206 induced G2/M cell cycle arrest and the appearance of the mitotic marker MPM-2 in K562 and K562R cells, which is associated with the upregulation of cyclin B1 and the dephosphorylation of Cdc2.

N-Stearoylsphingosine (Cer(d18:1/18:0)) is an amide compound widely found in eukaryotic organisms that enhances protein phosphatase 2A (PP2A) activity by interfering with the binding of PP2A to PP2A inhibitor 2, leading to dephosphorylation of Akt.N-Stearoylsphingosine is used in prostate cancer research.

Q134R, a neuroprotective derivative of hydroxyquinoline, effectively inhibits nuclear factor of activated T-cell (NFAT) signaling and possesses the ability to cross the blood-brain barrier. This compound shows promise for research into Alzheimer's disease (AD) and aging-related disorders[1].